VELETRI Reviews (EPOPROSTENOL SODIUM)

Average Rating: 3.5 (2 Ratings)

Filter Results

Compare VELETRI with similar:

 Type: Rx Drug

  

VELETRI  (EPOPROSTENOL SODIUM):  This medication is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). It helps to increase your ability to exercise and improve symptoms such as shortness of breath and tiredness. It works by relaxing and widening the blood vessels (arteries) in the lungs and other parts of the body so that blood can flow more easily. This medication belongs to a class of drugs known as vasodilators.   FDA Approval Date: 2008-06-27 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR VELETRICOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 5  For PH The only side effect after 6 months is pain in my feet. M 48 6 months
30
4/12/2020
 2  pulmonary hypertension nausea, diarrhea, headache, jaw pain, muscle ache and fatigue Veletri is IV infusion medication--a person has a permanent IV port put in chest and wears a pump 24/7, permanently with this medication. While it does work on lowering and stabilizing pulmonary hypertension, the side effects are horrendous. I will be discussing switching to a different medication with my doctor at next appointment as the side effects have not lessened in the 2+ years I have been on the medication. Quality of life is becoming a real issue for me. F 60 2 years
28 ng 1X day
1/2/2017
  

VELETRI  (EPOPROSTENOL SODIUM):  This medication is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). It helps to increase your ability to exercise and improve symptoms such as shortness of breath and tiredness. It works by relaxing and widening the blood vessels (arteries) in the lungs and other parts of the body so that blood can flow more easily. This medication belongs to a class of drugs known as vasodilators.   FDA Approval Date: 2008-06-27 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP